(Q40842175)

24 September 2017

Adjuvant therapy for pancreatic cancer: back to the future (English)

1 reference

24 September 2017

1 reference

W F Regine

1

1 reference

PubMed ID

9747820

24 September 2017

R A Abrams

series ordinal

2

1 reference

PubMed ID

9747820

24 September 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

International Journal of Radiation Oncology Biology Physics

24 September 2017

1 reference

24 September 2017

42

1 reference

24 September 2017

59-63

1 reference

24 September 2017

1

1 reference

24 September 2017

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Adjuvant therapy for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Cancer of the pancreas. 50 years of surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Should pancreaticoduodenectomy be performed in octogenarians?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Factors influencing survival after resection of pancreatic cancer. A DNA analysis and a histomorphologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900179-5

7 January 2021

10.1016/S0360-3016(98)00179-5

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9747820